We also evaluated the symptoms (e.g., fever, jaundice, pain abdomen, and loose motion), liver enzymes like serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamic-pyruvic transaminase (SGPT), and serum total bilirubin levels of the study participants.<h4>Methods</h4>This retrospective study analyzed the patients with suspected acute viral hepatitis who visited Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India, between January 2023 and November 2025. The gene discussed is GOT1; the disease is viral hepatitis.